BCL2 and pulmonary fibrosis: In this study, we found that the expression of caspase-3 and Bax in the model group increased, and the expression of Bcl-2 decreased, which were all reversed by AMI treatment in a dose-dependent manner,suggesting that AMI can inhibit alveolar epithelial cell apoptosis in pulmonary fibrosis.